Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action

Microbiology and Molecular Biology Reviews

Volumn 70, Issue 4, 2006, Pages 1032-1060

  Garcia M A ^a   Gil, J ^b   Ventoso, I ^c   Guerra, S ^a   Domingo, E ^a   Rivas, C ^d   Esteban, M ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ADENOVIRUS VECTOR; ANTIMITOTIC AGENT; ANTIVIRUS AGENT; CLOTRIMAZOLE; DOUBLE STRANDED RNA; GELDANAMYCIN; GROWTH FACTOR; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2; INTERFERON; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; PROTEIN KINASE R; PROTEIN P53; RADICICOL; RNA; STAT PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

5' UNTRANSLATED REGION; ALPHA CHAIN; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL FATE; CELL PROLIFERATION; CELL STRESS; CLINICAL TRIAL; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBUNIT; ESOPHAGUS CANCER; GLIOBLASTOMA; GLIOMA CELL; HUMAN; MELANOMA B16; NONHUMAN; NUCLEAR IMPORT; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; TRANSLATION REGULATION; VIRAL GENE THERAPY;

ANIMALS; ANTIVIRAL AGENTS; CELLS; CYTOLOGY; EIF-2 KINASE; HUMANS; INTERFERONS; SIGNAL TRANSDUCTION;

ANIMALIA; EUKARYOTA;

EID: 33845627785     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.00027-06     Document Type: Review

References (409)

1. Abraham, N., M. L. Jaramillo, P. I. Duncan, N. Methot, P. L. Icely, D. F. Stojdl, G. N. Barber, and J. C. Bell. 1998. The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia. Exp. Cell Res. 244: 394-404.
2. Alcami, A., and G. L. Smith. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69:4633-4639.
3. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
4. Arch, R. H., R. W. Gedrich, and C. B. Thompson. 1998. Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adapter proteins that regulates life and death. Genes Dev. 12:2821-2830.
5. Balachandran, S., and G. N. Barber. 2004. Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 5:51-65.
6. Balachandran, S., C. N. Kim, W. C. Yeh, T. W. Mak, K. Bhalla, and G. N. Barber. 1998. Activation of the dsRNA-dependent protein kinase, PKR. induces apoptosis through FADD-mediated death signaling. EMBO J. 17: 6888-6902.
7. Balachandran, S., P. C. Roberts, L. E. Brown, H. Truong, A. K. Pattnaik, D. R. Archer, and G. N. Barber. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141.
8. Baltzis, D., S. Li, and A. E. Koromilas. 2002. Functional characterization of pkr gene products expressed in cells from mice with a targeted deletion of the N terminus or C terminus domain of PKR. J. Biol. Chem. 277:38364-38372.
9. 8a. Baltzis, D., L.-K. Qu, S. Papadopaulou, J. D. Blais, J. C. Bell, N. Sonenherg, and A. E. Koromilas. 2004. Resistance to vesicular stomatitis virus infection requires a functional cross talk between the eukaryotic translation initiation factor 2α kinases PERK and PKR. J. Virol. 78:12747-12761.
10. Bannwarth, S., and A. Gatignol. 2005. HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. Curr. HIV Res. 3:61-71.
11. Barber, G. N. 2005. The dsRNA-dependent protein kinase. PKR and cell death. Cell Death Differ. 12:563-570.
12. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8:113-126.
13. Barber, G. N., S. Edelhoff, M. G. Katze, and C. M. Disteche. 1993. Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. Genomics 16:765-767.
14. Barber, G. N., R. Jagus, E. F. Meurs, A. G. Hovanessian, and M. G. Katze. 1995. Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J. Biol. Chem. 270:17423-17428.
15. Barber, G. N., S. Thompson, T. G. Lee, T. Strom, R. Jagus, A. Darveau, and M. G. Katze. 1994. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc. Natl. Acad. Sci. USA 91:4278-4282.
16. Beattie, E., E. Paoletti, and J. Tartaglia. 1995. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses. Virology 210:254-263.
17. Beere, H. M., B. B. Wolf, K. Cain, D. D. Mosser, A. Mahhouhi, T. Kuwana, P. Tailor, R. I. Morimoto, G. M. Cohen, and D. R. Green. 2000. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2:469-475.
18. Behrmann, I., H. Walczak, and P. H. Krammer. 1994. Structure of the human APO-1 gene. Eur. J. Immunol. 24:3057-3062.
19. Ben-Asouli, Y., Y. Banai, Y. Pel-Or, A. Shir, and R. Kaempfer. 2002. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108:221-232.
20. Benkirane, M., C. Neuveut, R. F. Chun, S. M. Smith, C. E. Samuel, A. Gatignol, and K. T. Jeang. 1997. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16:611-624.
21. Bennett, R. L., W. L. Blalock, and W. S. May. 2004. Serine 18 phosphorylation of RAX, the PKR activator, is required for PKR activation and consequent translation inhibition. J. Biol. Chem. 279:42687-42693.
22. Beretta, L., M. Gabbay, R. Berger, S. M. Hanash, and N. Sonenberg. 1996. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12:1593-1596.
23. Bergeron, J., T. Mahrouk, S. Garzon, and G. Lemay. 1998. Characterization of the thermosensitive ts453 reovirus mutant: increased dsRNA binding of sigma 3 protein correlates with interferon resistance. Virology 246:199-210.
24. Bergmann, M., A. Garcia-Sastre, E. Carnero, H. Pehamberger, K. Wolff, P. Palese, and T. Muster. 2000. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74:6203-6206.
25. Bertwistle, D., M. Sugimoto, and C. J. Sherr. 2004. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol. Cell. Biol. 24:985-996.
26. 24a. Beutler, B. 2004. Inferences, questions, and possibilities in Toll-like receptor signalling. Nature 430:257-263.
27. Billstrom, R., S. Heim, U. Kristoffersson, N. Mandahl, and F. Mitelman. 1990. Structural chromosomal abnormalities of 3q in myelodysplastic syndrome/acute myeloid leukaemia with Sweet's syndrome. Eur. J. Haematol. 45:150-152.
28. Bonnet, M. C., R. Weil, E. Dam, A. G. Hovanessian, and E. F. Meurs. 2000. PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex. Mol. Cell. Biol. 20:4532-4542.
29. Bottone, F. G., Jr., Y. Moon, J. S. Kim, B. Alston-Mills, M. Ishibashi, and T. E. Eling. 2005. The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Mol. Cancer Ther. 4:693-703.
30. Brand, S. R., R. Kobayashi, and M. B. Mathews. 1997. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272:8388-8395.
31. Brandt, T., M. C. Heck, S. Vijaysri, G. M. Jentarra, J. M. Cameron, and B. L. Jacobs. 2005. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response. Virology 333:263-270.
32. Brandt, T. A., and B. L. Jacobs. 2001. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J. Virol. 75:850-856.
33. Brun, A., C. Rivas, M. Esteban, J. M. Escribano, and C. Alonso. 1996. African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology 225:227-230.
34. Buchner, J. 1999. Hsp90 & Co. -a holding for folding. Trends Biochem. Sci. 24:136-141.
35. Burysek, L., and P. M. Pitha. 2001. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J. Virol. 75:2345-2352.
36. Cai, R., B. Carpick, R. F. Chun, K. T. Jeang, and B. R. Williams. 2000. HIV-1 TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch. Biochem. Biophys. 373:361-367.
37. Carpick, B. W., V. Graziano, D. Schneider, R. K. Maitra, X. Lee, and B. R. Williams. 1997. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-1 trans-activating region RNA. J. Biol. Chem. 272:9510-9516.
38. Carroll, K., O. Elroy-Stein, B. Moss, and R. Jagus. 1993. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J. Biol. Chem. 268:12837-12842.
39. Casano, F. J., A. M. Rolando, J. S. Mudgett, and S. M. Molineaux. 1994. The structure and complete nucleotide sequence of the murine gene encoding interleukin-1 beta converting enzyme (ICE). Genomics 20:474-481.
40. S11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain. J. Virol. 76:2029-2035.
41. Castelli, J. C., B. A. Hassel, A. Maran, J. Paranjape, J. A. Hewitt, X. L. Li, Y. T. Hsu, R. H. Silverman, and R. J. Youle. 1998 The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ. 5:313-320.
42. Castet, V., C. Fournier, A. Soulier, R. Brillet, J. Coste, D. Larrey, D. Dhumeaux, P. Maurel, and J. M. Pawlotsky. 2002. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. J. Virol. 76:8189-8199.
43. Caudell, E. G., J. B. Mumm, N. Poindexter, S. Ekmekcioglu, A. M. Mhashilkar, X. H. Yang, M. W. Retter, P. Hill, S. Chada, and E. A. Grimm. 2002. The protein product of the tumor suppressor gene, melanoma differentiation- associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 168:6041-6046.
44. Clemens, M. J. 2006. Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation. Int. J. Biochem. Cell Biol. 38:164-169.
45. Clemens, M. J. 1997. PKR-a protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell Biol. 29:945-949.
46. Clemens, M. J., J. W. Hershey, A. C. Hovanessian, B. C. Jacobs, M. G. Katze, R. J. Kaufman, P. Lengyel, C. E. Samuel, G. C. Sen, and B. R. Williams. 1993. PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J. Interferon Res. 13:241.
47. Colombo, E., J. C. Marine, D. Danovi, B. Falini, and P. G. Pelicci. 2002 Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell Biol. 4:529-533.
48. Cosentino, G. P., S. Venkatesan, K. C. Serluca, S. R. Green, M. B. Mathews, and N. Sonenberg. 1995. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA 92:9445-9449.
49. Craig, A. W., G. P. Cosentino, O. Donze, and N. Sonenberg. 1996. The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. J. Biol. Chem. 271:24526-24533.
50. Cuddihy, A. R., S. Li, N. W. Tam, A. H. Wong, Y. Taya, N. Abraham, J. C. Bell, and A. E. Koromilas. 1999. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol. Cell. Biol. 19:2475-2484.
51. Cuddihy, A. R., A. H. Wong, N. W. Tam, S. Li, and A. E. Koromilas. 1999. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18:2690-2702.
52. Cullen, B. R. 1993. Docs HIV-1 Tat induce a change in viral initiation rights? Cell 73:417-420.
53. Chan, W. Y., Q. R. Liu, J. Borjigin, H. Busch, O. M. Rennert, L. A. Tease, and P. K. Chan. 1989. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28:1033-1039.
54. Chang, H. W., J. C. Watson, and B. L. Jacobs. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89: 4825-4829.
55. Chatterjee, M., N. Chatterjee, R. Datta, B. Datta, and N. K. Gupta. 1998. Expression and activity of p67 are induced during heat shock. Biochem. Biophys. Res. Commun. 249:113-117.
56. Reference deleted.
57. Cheshire, J. L., B. R. Williams, and A. S. Baldwin, Jr. 1999. Involvement of double-stranded RNA-activated protein kinase in the synergistic activation of unclear factor-kappaB by tumor necrosis factor-alpha and gamma-interferon in preneuronal cells. J. Biol. Chem. 274:4801-4806.
58. Chong, K. L., L. Feng, K. Schappert, E. Meurs, T. F. Donahue, J. D. Friesen, A. G. Hovanessian, and B. R. Williams. 1992. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11:1553-1562.
59. Chou, J., E. R. Kern, R. J. Whitley, and B. Roizman. 1990. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250:1262-1266.
60. Chu, W. M., R. Ballard, B. W. Carpick, B. R. Williams, and C. W. Schmid. 1998. Potential Alu function: regulation of the activity of double-stranded RNA-activated kinase PKR. Mol. Cell. Biol. 18:58-68.
61. Chu, W. M., O. Ostertag, Z. W. Li, L. Chang, Y. Chen, Y. Hu, B. Williams, J. Perrault, and M. Karin. 1999. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11:721-731.
62. Chung, J. Y., Y. C. Park, H. Ye, and H. Wu. 2002. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115:679-688.
63. Daher, A., M. Longuet, D. Dorin, F. Bois, E. Segeral, S. Bannwarth, P. L. Battisti, D. F. Purcell, R. Benarous, C. Vaquero, E. F. Meurs, and A. Gatignol. 2001. Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J. Biol. Chem. 276: 33899-33905.
64. Dar, A. C., T. E. Dever, and F. Sicheri. 2005. Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Cell 122:887-900.
65. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630-1635.
66. Datta, B., D. Chakraharti, A. L. Roy, and N. K. Gupta. 1988. Roles of a 67-kDa polypeptide in reversal of protein synthesis inhibition in heme-deficient reticulocyte lysate. Proc. Natl. Acad. Sci. USA 85:3324-3328.
67. Datta, B., and R. Datta. 1999. Induction of apoptosis due to lowering the level of eukaryotic initiation factor 2-associated protein, p67, from mammalian cells by antisense approach. Exp. Cell Res. 246:376-383.
68. Datta, B., and R. Datta. 2003. Mutation at the acidic residue-rich domain of eukaryotic initiation factor 2 (eIF2alpha)-associated glycoprotein p67 increases the protection of eIF2alpha phosphorylation during heat shock. Arch. Biochem. Biophys. 413:116-122.
69. Datta, B., R. Datta, A. Ghosh, and A. Majumdar. 2004. Eukaryotic initiation factor 2-associated glycoprotein, p67, shows differential effects on the activity of certain kinases during serum-starved conditions. Arch. Biochem. Biophys. 427:68-78.
70. Datta, B., M. K. Ray, D. Chakrabarti, D. E. Wylie, and N. K. Gupta. 1989. Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 alpha-subunit. J. Bull. Chem. 264:20620-20624.
71. Datta, R., R. Tammali, and B. Datta. 2003. Negative regulation of the protection of eIF2alpha phosphorylation activity by a unique acidic domain present at the N-terminus of p67. Exp. Cell Res. 283:237-246.
72. Davies, M. V., H. W. Chang, B. L. Jacobs, and R. J. Kaufman. 1993. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67:1688-1692.
73. Davies, M. V., O. Elroy-Stein, R. Jagus, B. Moss, and R. J. Kaufman. 1992. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66:1943-1950.
74. Davis, S., and J. C. Watson. 1996. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proc. Natl. Acad. Sci. USA 93:508-513.
75. Deb, A., S. J. Haque, T. Mogensen, R. H. Silverman, and B. R. Williams. 2001. RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J. Immunol. 166:6170-6180.
76. Deb, A., M. Zamanian-Daryoush, Z. Xu, S. Kadereit, and B. R. Williams. 2001. Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. EMBO J. 20:2487-2496.
77. de Haro, C., R. Mendez, and J. Santoyo. 1996. The eIF-2alpha kinases and the control of protein synthesis. FASEB J. 10:1378-1387.
78. Delhem, N., A. Sahile, R. Gajardo, P. Podevin, A. Ahadie, M. A. Blaton, D. Kremsdorf, L. Beretta, and C. Brechot. 2001. Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 20:5836-5845.
79. Der, S. D., and A. S. Lau. 1995. Involvement of the double-stranded-RNA- dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc. Natl. Acad. Sci. USA 92:8841-8845.
80. Der, S. D., Y. L. Yang, C. Weissmann, and B. R. Williams. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:3279-3283.
81. Dever, T. E. 2002. Gene-specific regulation by general translation factors. Cell 108:545-556.
82. Dever, T. E., L. Feng, R. C. Wek, A. M. Cigan, T. F. Donahue, and A. G. Hinnebusch. 1992. Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 68:585-596.
83. Dey, M., C. Cao, A. C. Dar, T. Tamura, K. Ozato, F. Sicheri, and T. E. Dever. 2005. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122:901-913.
84. Diaz-Guerra, M., J. S. Kahn, and M. Esteban. 1993. A mutation of the nucleoside triphosphate phosphohydrolase I (NPH-1) gene confers sensitivity of vaccinia virus to interferon. Virology 197:485-491.
85. Diaz-Guerra, M., C. Rivas, and M. Esteban. 1997. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236: 354-363.
86. Donze, O., T. Abhas-Terki, and D. Picard. 2001. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 20:3771-3780.
87. Donze, O., J. Deng, J. Curran, R. Sladek, D. Picard, and N. Sonenberg. 2004. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J. 23:564-571.
88. Donze, O., R. Jagus, A. E. Koromilas, J. W. Hershey, and N. Sonenberg. 1995. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14:3828-3834.
89. Dorin, D., M. C. Bonnet, S. Bannwarth, A. Gatignol, E. F. Meurs, and C. Vaquero. 2003. The TAR RNA-binding protein. TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J. Biol. Chem. 278:4440-4448.
90. Dumbar, T. S., G. A. Gentry, and M. O. Olson. 1989. Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 28:9495-9501.
91. Edery, I., R. Petryshyn, and N. Sonenberg. 1989. Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism. Cell 56:303-312.
92. Elia, A., J. Vyas, K. G. Laing, and M. J. Clemens. 2004. Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein-Barr virus small RNA EBER-1. Eur. J. Biochem. 271:1895-1905.
93. Endo-Munoz, L., T. Warby, D. Harrich, and N. A. McMillan. 2005. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virol. J. 2:17.
94. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, N. Izumi, F. Marumo, and C. Sato. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Investig. 96:224-230.
95. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, and C. Sato. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334:77-81.
96. Esteban, M., M. A. Garcia, E. Domingo-Gil, J. Arroyo, C. Nombela, and C. Rivas. 2003. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation. J. Gen. Virol. 84:1463-1470.
97. Reference deleted.
98. Falcon, A. M., P. Fortes, R. M. Marion, A. Beloso, and J. Ortin. 1999. Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res. 27:2241-2247.
99. Falini, B., C. Mecucci, E. Tiacci, M. Alcalay, R. Rosati, L. Pasqualucci, R. La Starza, D. Diverio, E. Colombo, A. Santucci, B. Bigerna, R. Pacini, A. Pucciarini, A. Liso, M. Vignetti, P. Fazi, N. Meani, V. Pettirossi, G. Saglio, F. Mandelli, F. Lo-Coco, P. G. Pelicci, and M. F. Martelli. 2005. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352:254-265.
100. Fickenscher, H., S. Hor, H. Kupers, A. Knappe, S. Wittmann, and H. Sticht. 2002. The interleukin-10 family of cytokines. Trends Immunol. 23:89-96.
101. Flati, V., S. J. Haque, and B. R. Williams. 1996. Interferon-alpha- induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three. EMBO J. 15:1566-1571.
102. Friedman, R. M., D. H. Metz, R. M. Esteban, D. R. Tovell, L. A. Ball, and I. M. Kerr. 1972. Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J. Virol. 10:1184-1198.
103. 99a. Freidrich, I., H. Ben-Bassat, and A. Levitzki. 2005. Activation of dsRNA dependent protein kinase PKR in Karpas299 does not lead to cell death. Cancer Biol. Ther. 4:734-739.
104. Gaestel, M. 2006. MAPKAP kinases-MKs-two's company, three's a crowd. Nat. Rev. Mol. Cell Biol. 7:120-130.
105. Galahru, J., and A. Hovanessian. 1987. Autophosphorylation of the protein kinase dependent on double-stranded RNA. J. Biol. Chem. 262:15538-15544.
106. Gale, M., Jr., C. M. Blakely, A. Darveau, P. R. Romano, M. J. Korth, and M. G. Katze. 2002. P52rIPK regulates the molecular cochaperone P58IPK to mediate control of the RNA-dependent protein kinase in response to cytoplasmic stress. Biochemistry 41:11878-11887.
107. Gale, M., Jr., C. M. Blakely, B. Kwieciszewski, S. L. Tan, M. Dossett, N. M. Tang, M. J. Korth, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18:5208-5218.
108. Gale, M., Jr., B. Kwieciszewski, M. Dossett, H. Nakao, and M. G. Katze. 1999. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73:6506-6516.
109. Gale, M., Jr., S. L. Tan, M. Wambach, and M. G. Katze. 1996. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation. Mol. Cell. Biol. 16:4172-4181.
110. Gale, M. J., Jr., M. J. Korth, and M. G. Katze. 1998. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin. Diagn. Virol. 10:157-162.
111. Gale, M. J., Jr., M. J. Korth, N. M. Tang, S. L. Tan, D. A. Hopkins, T. E. Dever, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227.
112. Garcia, M. A., M. Collado, C. Munoz-Fontela, A. Matheu, L. Marcos-Villar, J. Arroyo, M. Esteban, M. Serrano, and C. Rivas. 2006. Antiviral action of the tumor suppressor ARF. EMBO J. 25:4284-4292.
113. Garcia, M. A., S. Guerra, J. Gil, V. Jimenez, and M. Esteban. 2002. Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene 21:8379-8387.
114. Gatignol, A., A. Buckler-While, B. Berkhout, and K. T. Jeang. 1991. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251:1597-1600.
115. Gatignol, A., A. Kumar, A. Rahson, and K. T. Jeang. 1989. Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA. Proc. Natl. Acad. Sci. USA 86:7828-7832.
116. Gerotto, M., F. Dal Pero, P. Pontisso, F. Noventa, A. Gatta, and A. Alberti. 2000. Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon. Gastroenterology 119:1649-1655.
117. Ghosh, A. K., R. Steele, K. Meyer, R. Ray, and R. B. Ray. 1999. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J. Gen. Virol. 80:1179-1183.
118. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81-S96.
119. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rcl proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
120. Gil, J., J. Alcami, and M. Esteban. 2000. Activation of NF-kappa B by the dsRNA-dependent protein kinase, PKR, involves the I kappa B kinase complex. Oncogene 19:1369-1378.
121. Gil, J., J. Alcami, and M. Esteban. 1999. Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-κB. Mol. Cell. Biol. 19:4653-4663.
122. Gil, J., and M. Esteban. 2000. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5:107-114.
123. Gil, J., and M. Esteban. 2000. The interferon-induced protein kinase (PKR) triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene 19:3665-3674.
124. Gil, J., M. Esteban, and D. Roth. 2000. In vivo regulation of the dsRNA-dependent protein kinase PKR by the cellular glycoprotein p67. Biochemistry 39:16016-16025.
125. Gil, J., M. A. Garcia, and M. Esteban. 2002. Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance. FEBS Lett. 529:249-255.
126. Gil, J., M. A. Garcia, P. Gomez-Puertas, S. Guerra, J. Rullas, H. Nakano, J. Alcami, and M. Esteban. 2004. TRAF family proteins link PKR with NF-κB activation. Mol. Cell. Biol. 24:4502-4512.
127. Gil, J., J. Rullas, J. Alcami, and M. Esteban. 2001. MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKR. J. Gen. Virol. 82:3027-3034.
128. Gil, J., J. Rullas, M. A. Garcia, J. Alcami, and M. Esteban. 2001. The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-kappaB activation. Oncogene 20:385-394.
129. Gil, J., and M. Esteban. 2004. Vaccinia virus recombinants as a model system to analyze IFN-induced pathways. J. Interferon Cytokine Res. 24: 637-646.
130. Gimenez-Barcons, M., S. Franco, Y. Suarez, X. Forns, S. Ampurdanes, F. Puig-Basagoiti, A. Sanchez-Fueyo, J. M. Barrera, J. M. Llovet, J. Bruix, J. M. Sanchez-Tapias, J. Rodes, and J. C. Saiz. 2001. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis. Hepatology 34:158-167.
131. Goh, K. C., M. J. deVeer, and B. R. Williams. 2000. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19:4292-4297.
132. Gohda, J., T. Matsumura, and J. Inoue. 2004. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J. Immunol. 173:2913-2917.
133. Gomez, C. E., A. M. Vandermeeren, M. A. Garcia, E. Domingo-Gil, and M. Esteban. 2005. Involvement of PKR and RNase L in translational control and induction of apoptosis after hepatitis C polyprotein expression from a vaccinia virus recombinant. Virol. J. 2:81.
134. Gonzalez-Lopez, C., J. Martinez-Costas, M. Esteban, and J. Benavente. 2003. Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinase. J. Gen. Virol. 84:1629-1639.
135. Goodhourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81:2341-2364.
136. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281:1309-1312.
137. Guerra, S., L. A. Lopez-Fernandez, R. Conde, A. Pascual-Montano, K. Harshman, and M. Esteban. 2004. Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J. Virol. 78:5820-5834.
138. Guerra, S., L. A. Lopez-Fernandez, M. A. Garcia, A. Zaballos, and M. Esteban. 2006. Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosis. J. Biol. Chem. 281:18734-18745.
139. Gunnery, S., S. R. Green, and M. B. Mathews. 1992. Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function. Proc. Natl. Acad. Sci. USA 89:11557-11561.
140. Gunnery, S., A. P. Rice, H. D. Robertson, and M. B. Mathews. 1990. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 87:8687-8691.
141. Haase, A. D., L. Jaskiewicz, H. Zhang, S. Laine, R. Sack, A. Gatignol, and W. Filipowicz. 2005. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 6:961-967.
142. Hacker, H., V. Redecke, B. Blagoev, I. Kratchmarova, L. C. Hsu, G. G. Wang, M. P. Kamps, E. Raz, H. Wagner, G. Hacker, M. Mann, and M. Karin. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-207.
143. Hai, T., and M. G. Hartman. 2001. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273:1-11.
144. Hai, T., C. D. Wolfgang, D. K. Marsee, A. E. Allen, and U. Sivaprasad. 1999. ATF3 and stress responses. Gene Expr. 7:321-335.
145. Haines, G. K., III, S. Becker, G. Ghadge, M. Kies, H. Pelzer, and J. A. Radosevich. 1993. Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region. Arch. Otolaryngol. Head Neck Surg. 119:1142-1147.
146. Haines, G. K., III, R. J. Panos, P. M. Bak, T. Brown, M. Zielinski, J. Leyland, and J. A. Radosevich. 1998. Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma. Tumour Biol. 19:52-59.
147. Haines, G. K., R. Cajulis, R. Hayden, R. Duda, M. Talamonti, and J. A. Radosevich. 1996. Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol. 17:5-12.
148. Haines, G. K., G. Ghadge, K. Thimmappaya, and J. A. Radosevich. 1992. Expression of the protein kinase p-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms. Virchows Arch. B 62:151-158.
149. Haines, G. K., G. D. Ghadge, S. G. Combs, W. Leslie, B. Thimmappaya, and J. A. Radosevich. 1992. Immunohistochemical detection of double-stranded-RNA- dependent protein kinase (p68) with a novel monoclonal antibody TJ4C4. A case report of an AIDS-associated Kaposi's sarcoma treated with alpha-interferon. Tumour Biol. 13:324-329.
150. Harding, H. P., I. Novoa, Y. Zhang, H. Zeng, R. Wek, M. Schapira, and D. Ron. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6:1099-1108.
151. Hartman, M. G., D. Lu, M. L. Kim, G. J. Kociba, T. Sbukri, J. Buteau, X. Wang, W. L. Frankel, D. Guttridge, M. Prentki, S. T. Grey, D. Ron, and T. Hai.
152. Hatada, E., S. Saito, and R. Fukuda. 1999. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J. Virol. 73:2425-2433.
153. Haus, O. 2000. The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer. Arch. Immunol. Ther. Exp. (Warsz) 48:95-100.
154. - herpes simplex virus 1: failure of activated RNA-dependent protein kinase to shut off protein synthesis is associated with a deletion in the domain of the α47 gene. J. Virol. 71:6049-6054.
155. He, B., M. Gross, and B. Roizman. 1998. The gamma134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J. Biol. Chem. 273:20737-20743.
156. He, B., M. Gross, and B. Roizman. 1947. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94:843-848.
157. Hershey, J. W. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717-755.
158. Hii, S. I., L. Hardy, T. Crough, E. J. Payne, K. Grimmett, D. Gill, and N. A. McMillan. 2004. Loss of PKR activity in chronic lymphocytic leukemia. Int. J. Cancer 109:329-335.
159. Horng, T., G. M. Barton, and R. Medzhitov. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:835-841.
160. Hovanessian, A. G. 1989. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J. Interferon Res. 9:641-647.
161. Hovanessian, A. G., and J. Galabru. 1987. The double-stranded RNA-dependent protein kinase is also activated by heparin. Eur. J. Biochem. 167:467-473.
162. Hovanessian, A. G., and I. M. Kerr. 1979. The (2′-5′) oligoadenylate (pppA2′-5′A2′-5′A) synthetase and protein kinase(s) from interferon-treated cells. Eur. J. Biochem. 93:515-526.
163. Hsu, L. C., J. M. Park, K. Zhang, J. L. Luo, S. Maeda, R. J. Kaufman, L. Eckmann, D. G. Guiney, and M. Karin. 2004. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428:341-345.
164. Icely, P. L., P. Gros, J. J. Bergeron, A. Devault, D. E. Afar, and J. C. Bell. 1991. TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine. J. Biol. Chem. 266:16073-16077.
165. Iordanov, M. S., O. P. Ryabinina, P. Schneider, and B. E. Magun. 2005. Two mechanisms of caspase 9 processing in double-stranded RNA- and virus-triggered apoptosis. Apoptosis 10:153-166.
166. Isaacs, A., and J. Lindenmann. 1957. Virus interference. 1. The interferon. Proc. R Soc. London B 147:258-267.
167. Itahana, K., K. P. Bhat, A. Jin, V. Itahana, D. Ilawke, R. Kobayashi, and Y. Zhang. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 12:1151-1164.
168. Ito, T., R. Jagus, and W. S. May. 1994. Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91:7455-7459.
169. Ito, T., M. Yang, and W. S. May. 1999. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 274:15427-15432.
170. Iwamura, T., M. Yoneyama, N. Koizumi, Y. Okabe, H. Namiki, C. E. Samuel, and T. Fujita. 2001. PACT, a double-stranded RNA binding protein acts as a positive regulator for type 1 interferon gene induced by Newcastle disease virus. Biochem. Biophys. Res. Commun. 282:515-523.
171. Iwamura, T., M. Yoneyama, K. Yamaguchi, W. Suhara, W. Mori, K. Shiota, Y. Okabe, H. Namiki, and T. Fujita. 2001. Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6:375-388.
172. Jacobs, B. L., and J. O. Langland. 1998. Reovirus sigma 3 protein: dsRNA binding and inhibition of RNA-activated protein kinase. Curr. Top. Microbiol. Immunol. 233:185-196.
173. Jacquemont, B., and B. Roizman. 1975. RNA synthesis in cells infected with herpes simplex virus. X. Properties of viral symmetric transcripts and of double-stranded RNA prepared from them. J. Virol. 15:707-713.
174. Jagus, R., and M. M. Gray. 1994. Proteins that interact with PKR. Biochimie 76:779-791.
175. Jagus, R., B. Joshi, and G. N. Barber. 1999. PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 31:123-138.
176. Jeffrey, I. W., S. Kadereit, E. F. Meurs, T. Metzger, M. Bachmann, M. Schwemmle, A. G. Hovanessian, and M. J. Clemens. 1995. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell Res. 218:17-27.
177. Jiang, H. Y., S. A. Wek, B. C. McGrath, D. Lu, T. Hai, H. P. Harding, X. Wang, D. Ron, D. R. Cavener, and R. C. Wek. 2004. Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol. Cell. Biol. 24:1365-1377.
178. Jiang, Z., M. Zamanian-Daryoush, H. Nie, A. M. Silva, B. R. Williams, and X. Li. 2003. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 278:16713-16719.
179. Jindal, S., and R. A. Young. 1992. Vaccinia virus infection induces a stress response that leads to association of Hsp70 with viral proteins. J. Virol. 66:5357-5362.
180. Jing, X., M. Cerveny, K. Yang, and B. He. 2004. Replication of herpes simplex virus 1 depends on the gamma 134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection. J. Virol. 78:7653-7666.
181. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
182. Kadereit, S., H. Xu, T. M. Engeman, Y. L. Yang, R. L. Fairchild, and B. R. Williams. 2000. Negative regulation of CD8+ T cell function by the IFN-induced and double-stranded RNA-activated kinase PKR. J. Immunol. 165:6896-6901.
183. Kadowaki, N., S. Ho, S. Antonenko, R. W. Malefyt, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:863-869.
184. Kaempfer, R. 2003. RNA sensors: novel regulators of gene expression. EMBO Rep. 4:1043-1047.
185. Kang, D. C., R. V. Gopalkrishnan, Q. Wu, E. Jankowsky, A. M. Pyle, and P. B. Fisher. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 99:637-642.
186. Kasibhatla, S., T. Brunner, L. Genestier, F. Echeverri, A. Mahbouhi, and D. R. Green. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol. Cell 1:543-551.
187. Katze, M. G. 2002. Interferon, PKR, virology, and genomics: what is past and what is next in the new millennium? J. Interferon Cytokine Res. 22:283-286.
188. Katze, M. G. 1995. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3:75-78.
189. Kaufman, R. J. 1999. Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proc. Natl. Acad. Sci. USA 96:11693-11695.
190. Kaufman, R. J., M. V. Davies, V. K. Pathak, and J. W. Hershey. 1989. The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol. Cell. Biol. 9:946-958.
191. Kawagishi-Kobayashi, M., J. B. Silverman, T. L. Ung, and T. E. Dever. 1997. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2α. Mol. Cell. Biol. 17:4146-4158.
192. Kawakubo, K., K. L. Kuhen, J. W. Vessey, C. X. George, and C. E. Samuel. 1999. Alternative splice variants of the human PKR protein kinase possessing different 5′-untranslated regions: expression in untreated and interferon-treated cells and translational activity. Virology 264:106-114.
193. Kawauchi, J., C. Zhang, K. Nobori, Y. Hashimoto, M. T. Adachi, A. Noda, M. Sunamori, and S. Kitajima. 2002. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J. Biol. Chem. 277:39025-39034.
194. Kazemi, S., S. Papadopoulou, S. Li, Q. Su, S. Wang, A. Yoshimura, G. Matlashewski, T. E. Dever, and A. E. Koromilas. 2004. Control of α subunit of eukaryotic translation initiation factor 2 (eIF2α) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2α-dependent gene expression and cell death. Mol. Cell. Biol. 24:3415-3429.
195. Kerr, I. M., R. E. Brown, and L. A. Ball. 1974. Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment. Nature 250:57-59.
196. Khoo, D., C. Perez, and I. Mohr. 2002. Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation. J. Virol. 76:11971-11981.
197. Kibler, K. V., T. Shors, K. B. Perkins, C. C. Zeman, M. P. Banaszak, J. Biesterfeldt, J. O. Langland, and B. L. Jacobs. 1997. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71:1992-2003.
198. Kim, I., C. W. Liu, and J. D. Puglisi. 2006. Specific recognition of HIV TAR RNA by the dsRNA binding domains (dsRBD1-dsRBD2) of PKR. J. Mol. Biol. 358:430-442.
199. Kim, S. H., A. P. Forman, M. B. Mathews, and S. Gunnery. 2000. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 19:3086-3094.
200. Kim, S. H., S. Gunnery, J. K. Choe, and M. B. Mathews. 2002. Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene 21:8741-8748.
201. Kim, Y. G., M. Muralinath, T. Brandt, M. Pearcy, K. Hauns, K. Lowenhaupt, B. L. Jacobs, and A. Rich. 2003. A role for Z-DNA binding in vaccinia virus pathogenesis. Proc. Natl. Acad. Sci. USA 100:6974-6979.
202. Kirchhoff, S., A. E. Koromilas, F. Schaper, M. Grashoff, N. Sonenberg, and H. Hauser. 1995. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11:439-445.
203. Koromilas, A. E., S. Roy, G. N. Barber, M. G. Katze, and N. Sonenberg. 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685-1689.
204. Kronfeld-Kinar, Y., S. Vilchik, T. Hyman, F. Leibkowicz, and S. Salzberg. 1999. Involvement of PKR in the regulation of myogenesis. Cell Growth Differ. 10:201-212.
205. Kuhen, K. L., X. Shen, E. R. Carlisle, A. L. Richardson, H. U. Weier, H. Tanaka, and C. E. Samuel. 1996. Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. Genomics 36:197-201.
206. Kumar, A., J. Haque, J. Lacoste, J. Hiscott, and B. R. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating 1 kappa B. Proc. Natl. Acad. Sci. USA 91:6288-6292.
207. Kumar, A., Y. L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, and B. R. Williams. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16:406-416.
208. Kumar, K. U., S. P. Srivastava, and R. J. Kaufman. 1999. Double-stranded RNA-activated protein kinase (PKR) is negatively regulated by 60S ribosomal subunit protein L18. Mol. Cell. Biol. 19:1116-1125.
209. Kuyama, M., G. Nakanishi, J. Arata, K. Iwatsuki, and W. Fujimoto. 2003. Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia. J. Dermatol. 30:579-589.
210. Kwon, H. C., C. H. Moon, S. H. Kim, H. J. Choi, H. S. Lee, M. S. Roh, T. H. Hwang, J. S. Kim, and H. J. Kim. 2005. Expression of double-stranded RNA-activated protein kinase (PKR) and its prognostic significance in lymph node negative rectal cancer. Jpn. J. Clin. Oncol. 35:545-550.
211. Kwon, J. A., and A. Rich. 2005. Biological function of the vaccinia virus Z-DNA-binding protein E3L: gene transactivation and antiapoptotic activity in HeLa cells. Proc. Natl. Acad. Sci. USA 102:12759-12764.
212. Kyriakis, J. M., and J. Avruch. 1996. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18:567-577.
213. Laing, K. G., A. Elia, I. Jeffrey, V. Matys, V. J. Tilleray, B. Souberbielle, and M. J. Clemens. 2002. In vivo effects of the Epstein-Barr virus small RNA EBER-I on protein synthesis and cell growth regulation. Virology 297:253-269.
214. Langland, J. O., and B. L. Jacobs. 2004. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology 324:419-429.
215. Langland, J. O., and B. L. Jacobs. 2002. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 299:133-141.
216. Laurent, A. G., B. Krust, J. Galabru, J. Svab, and A. G. Hovanessian. 1985. Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. Proc. Natl. Acad. Sci. USA 82:4341-4345.
217. Reference deleted.
218. Lee, J. H., E. J. Park, O. S. Kim, H. Y. Kim, E. H. Joe, and I. Jou. 2005. Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells. Glia 50:66-79.
219. Lee, S. B., R. Bablanian, and M. Esteban. 1996. Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. J. Interferon Cytokine Res. 16:1073-1078.
220. Lee, S. B., and M. Esteban. 1994. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199:491-496.
221. Lee, S. B., Z. Melkova, W. Yan, B. R. Williams, A. G. Hovanessian, and M. Esteban. 1993. The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells. Virology 192:380-385.
222. Lee, S. B., D. Rodriguez, J. R. Rodriguez, and M. Esteban. 1997. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology 231:81-88.
223. Lee, T. G., N. Tang, S. Thompson, J. Miller, and M. G. Katze. 1994. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 14:2331-2342.
224. Lee, T. G., J. Tomita, A. G. Hovanessian, and M. G. Katze. 1992. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J. Biol. Chem. 267:14238-14243.
225. Lee, T. G., J. Tomita, A. G. Hovanessian, and M. G. Katze. 1990. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA 87:6208-6212.
226. Lehner, P. J., and P. Cresswell. 1996. Processing and delivery of peptides presented by MHC class 1 molecules. Curr. Opin. Immunol. 8:59-67.
227. Leib, D. A., M. A. Machalek, B. R. Williams, R. H. Silverman, and H. W. Virgin. 2000. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA 97:6097-6101.
228. Leitner, W. W., L. N. Hwang, M. J. deVeer, A. Zhou, R. H. Silverman, B. R. Williams, T. W. Dubensky, H. Ying, and N. P. Restifo. 2003. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 9:33-39.
229. Lengyel, P. 1993. Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. USA 90:5893-5895.
230. Li, J. C., D. C. Lee, B. K. Cheung, and A. S. Lau. 2005. Mechanisms for HIV Tat upregulation of IL-10 and other cytokine expression: kinase signaling and PKR-mediated immune response. FEBS Lett. 579:3055-3062.
231. Li, S., and A. E. Koromilas. 2001. Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. J. Biol. Chem. 276:13881-13890.
232. Li, S., J. Y. Min, R. M. Krug, and G. C. Sen. 2006. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13-21.
233. Li, S., K. Nagai, and A. E. Koromilas. 2000. A diminished activation capacity of the interferon-inducible protein kinase PKR in human T lymphocytes. Eur. J. Biochem. 267:1598-1606.
234. Li, S., G. A. Peters, K. Ding, X. Zhang, J. Qin, and G. C. Sen. 2006. Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl. Acad. Sci. USA 103:10005-10010.
235. Liu, Y., K. C. Wolff, B. L. Jacobs, and C. E. Samuel. 2001. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. Virology 289:378-387.
236. Lu, D., C. D. Wolfgang, and T. Hai. 2006. Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J. Biol. Chem. 281:10473-10481.
237. Lu, P. D., H. P. Harding, and D. Ron. 2004. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J. Cell Biol. 167:27-33.
238. Lu, Y., M. Wambach, M. G. Katze, and R. M. Krug. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214:222-228.
239. Lubyova, B., and P. M. Pitha. 2000. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J. Virol. 74:8194-8201.
240. MacLean, A. R., M. ul-Fareed, L. Robertson, J. Harland, and S. M. Brown. 1991. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence. J. Gen. Virol. 72:631-639.
241. Majumdar, R., and U. Maitra. 2005. Regulation of GTP hydrolysis prior to ribosomal AUG selection during eukaryotic translation initiation. EMBO J. 24:3737-3746.
242. Malathi, K., J. M. Paranjape, E. Bulanova, M. Shim, J. M. Guenther-Johnson, P. W. Faber, T. E. Eling, B. R. Williams, and R. H. Silverman. 2005. A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L. Proc. Natl. Acad. Sci. USA 102:14533-14538.
243. Manche, L, S. R. Green, C. Schmedt, and M. B. Mathews. 1992. Interactions between double-stranded RNA regulators and the protein kinase DA1. Mol. Cell. Biol. 12:5238-5248.
244. Maran, A., R. K. Maitra, A. Kumar, B. Dong, W. Xiao, G. Li, B. R. Williams, P. F. Torrence, and R. H. Silverman. 1994. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265:789-792.
245. Maran, A., and M. B. Mathews. 1988. Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA. Virology 164: 106-113.
246. Markert, J. M., M. D. Medlock, S. D. Rabkin, G. Y. Gillespie, T. Todo, W. D. Hunter, C. A. Palmer, F. Feigenbaum, C. Tornatore, F. Tufaro, and R. L. Martuza. 2000. Conditionally replicating herpes simplex virus mutant. G207, for the treatment of malignant glioma: results of a phase 1 trial. Gene Ther. 7:867-874.
247. Martinez-Costas, J., C. Gonzalez-Lopez, V. N. Vakharia, and J. Benavente. 2000. Possible involvement of the double-stranded RNA-binding core protein σA in the resistance of avian reovirus to interferon. J. Virol. 74:1124-1131.
248. McMillan, N. A., R. F. Chun, D. P. Siderovski, J. Galabru, W. M. Tuone, C. E. Samuel, T. W. Mak, A. G. Hovanessian, K. T. Jeang, and B. R. Williams. 1995. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213:413-424.
249. Metz, D. H., and M. Esteban. 1972. Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus. Nature 238:385-388.
250. Meurs, E., K. Chong, J. Galabru, N. S. Thomas, I. M. Kerr, B. R. Williams, and A. G. Hovanessian. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390.
251. Meurs, E. F., J. Galabru, G. N. Barber, M. G. Katze, and A. G. Hovanessian. 1993. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 90:232-236.
252. Mhashilkar, A. M., A. L. Stewart, K. Sieger, H. Y. Yang, A. H. Khimani, I. Ito, Y. Saito, K. K. Hunt, E. A. Grimm, J. A. Roth, R. E. Meyn, R. Ramesh, and S. Chada. 2003. MDA-7 negatively regulates the beta-catenin and P13K signaling pathways in breast and lung tumor cells. Mol. Ther. 8:207-219.
253. Mohr, I., and Y. Gluzman. 1996. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 15:4759-4766.
254. Morimoto, H., A. Ozaki, H. Okamura, K. Yoshida, S. Kitamura, and T. Haneji. 2005. Okadaic acid induces tyrosine phosphorylation of IkappaBalpha that mediated by PKR pathway in human osteoblastic MG63 cells. Mol. Cell. Biochem. 276:211-217.
255. Morris, S. W., M. N. Kirstein, M. B. Valentine, K. G. Dittmer, D. N. Shapiro, D. L. Saltman, and A. T. Look. 1994. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284.
256. Mosser, D. D., A. W. Caron, L. Bourget, A. B. Meriin, M. Y. Sherman, R. I. Morimoto, and B. Massie. 2000. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol. Cell. Biol. 20:7146-7159.
257. Mulvey, M., J. Poppers, D. Sternberg, and I. Mohr. 2003. Regulation of eIF2α phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J. Virol. 77:10917-10928.
258. Mundschau, L. J., and D. V. Faller. 1994. Endogenous inhibitors of the dsRNA-dependent eIF-2 alpha protein kinase PKR in normal and ras- transformed cells. Biochimie 76:792-800.
259. Mundschau, L. J., and D. V. Faller. 1995. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J. Biol. Chem. 270:3100-3106.
260. Munoz-Fontela, C., M. Collado, E. Rodriguez, M. A. Garcia, A. Alvarez-Barrientos, J. Arroyo, C. Nombela, and C. Rivas. 2005. Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus. Exp. Cell Res. 311:96-105.
261. Murad, J. M., L. G. Tone, L. R. de Souza, and F. L. De Lucca. 2005. A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia. Blood Cells Mol. Dis. 34:1-5.
262. Nanbo, A., K. Inoue, K. Adachi-Takasawa, and K. Takada. 2002 Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J. 21:954-965.
263. Nanduri, S., B. Carpick, Y. Yang, B. R. Williams, and J. Qin. 1998. 1H, 13C 15N resonance assignment of the 20 kDa double stranded RNA binding domain of PKR. J. Biomol. NMR 12:349-351.
264. Nanduri, S., B. W. Carpick, Y. Yang, B. R. Williams, and J. Qin. 1998. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17:5458-5465.
265. Nawa, T., M. T. Nawa, M. T. Adachi, I. Uchimura, R. Shimokawa, K. Fujisawa, A. Tanaka, F. Numano, and S. Kitajima. 2002. Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 161:281-291.
266. Noguchi, T., S. Satoh, T. Noshi, E. Hatada, R. Fukuda, A. Kawai, S. Ikeda, M. Hijikata, and K. Shimotohno. 2001. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Microbiol. Immunol. 45:829-840.
267. Nozawa, Y., N. Van Belzen, A. C. Van der Made, W. N. Dinjens, and F. T. Bosman. 1996. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J. Pathol. 178:48-52.
268. Nussbaum, J. M., S. Gunnery, and M. B. Mathews. 2002. The 3′-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR. Nucleic Acids Res. 30:1205-1212.
269. Nussbaum, J. M., M. Major, and S. Gunnery. 2003. Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer. Cancer Lett. 196:207-216.
270. Offermann, M. K., J. Zimring, K. H. Mellits, M. K. Hagan, R. Shaw, R. M. Medford, M. B. Mathews, S. Goodbourn, and R. Jagus. 1995. Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly (I), poly (C) in endothelial cells. Eur. J. Biochem. 232:28-36.
271. Oganesyan, G., S. K. Saha, B. Guo, J. Q. He, A. Shahangian, B. Zarnegar, A. Perry, and G. Cheng. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439:208-211.
272. Olson, M. O., M. O. Wallace, A. H. Herrera, L. Marshall-Carlson, and R. C. Hunt. 1986. Preribosomal ribonuclecoprotein particles are a major component of a nucleolar matrix fraction. Biochemistry 25:484-491.
273. Ong, C. L., J. C. Thorpe, P. R. Gorry, S. Bannwarth, A. Jaworowski, J. L. Howard, S. Chung, S. Campbell, H. S. Christensen, G. Clerzius, A. J. Mouland, A. Gatignol, and D. F. Purcell. 2005. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J. Virol. 79:12763-12772.
274. Onuki, R., Y. Bando, E. Suyama, T. Katayama, H. Kawasaki, T. Baba, M. Tohyama, and K. Taira. 2004. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 23:959-968.
275. Paez, E., and M. Esteban. 1984. Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp(A2′p)nA-synthetase. Virology 134:29-39.
276. Paez, E., and M. Esteban. 1984. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology 134:12-28.
277. Pang, Q., T. A. Christianson, W. Keeble, T. Koretsky, and G. C. Bagby. 2002. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J. Biol. Chem. 277:49638-49643.
278. Pang, Q., T. A. Christianson, T. Koretsky, H. Carlson, L. David, W. Keehle, G. R. Faulkner, A. Speckhart, and G. C. Bagby. 2003. Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR. J. Biol. Chem. 278:41709-41717.
279. Park, H., M. V. Davies, J. O. Langland, H. W. Chang, Y. S. Nam, J. Tartaglia, E. Paoletti, B. L. Jacobs, R. J. Kaufman, and S. Venkatesan. 1994. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl. Acad. Sci. USA 91:4713-4717.
280. Pataer, A., S. Chada, K. K. Hunt, J. A. Roth, and S. G. Swisher. 2003. Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. J. Thorac. Cardiovasc. Surg. 125:1328-1335.
281. Pataer, A., S. A. Vorburger, G. N. Barber, S. Chada, A. M. Mhashilkar, H. Zou-Yang, A. L. Stewart, S. Balachandran, J. A. Roth, K. K. Hunt, and S. G. Swisher. 2002. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via upregulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. 62:2239-2243.
282. Pataer, A., S. A. Vorburger, S. Chada, S. Balachandran, G. N. Barber, J. A. Roth, K. K. Hunt, and S. G. Swisher. 2005. Melanoma differentiation- associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol. Ther. 11:717-723.
283. Patel, C. V., I. Handy, T. Goldsmith, and R. C. Patel. 2000. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 275:37993-37998.
284. Patel, R. C., and G. C. Sen. 1998. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17:4379-4390.
285. Peel, A. L. 2004. PKR activation in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 63:97-105.
286. Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202:8-32.
287. Peters, G. A., R. Hartmann, J. Qin, and G. C. Sen. 2001. Modular structure of PACT: distinct domains for binding and activating PKR. Mol. Cell. Biol. 21:1908-1920.
288. Peters, G. A., D. Khoo, I. Mohr, and G. C. Sen. 2002. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J. Virol. 76:11054-11064.
289. Petryshyn, R. A., J. Li, and R. Judware. 1994. Activation of the dsRNA-dependent kinase. Prog. Mol. Subcell. Biol. 14:1-14.
290. Reference deleted.
291. Pomerantz, J. L., and D. Baltimore. 2002. Two pathways to NF-κB. Mol. Cell 10:693-695.
292. Poppers, J., M. Mulvey, C. Perez, D. Khoo, and I. Mohr. 2003. Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J. Virol. 77:228-236.
293. Prostko, C. R., J. N. Dholakia, M. A. Brostrom, and C. O. Brostrom. 1995. Activation of the double-stranded RNA-regulated protein kinase by depletion of endoplasmic reticular calcium stores. J. Biol. Chem. 270:6211-6215.
294. Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247-1255.
295. Ramana, C. V., N. Grammatikakis, M. Chernov, H. Nguyen, K. C. Goh, B. R. Williams, and G. R. Stark. 2000. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J. 19:263-272.
296. Rampling, R., G. Cruickshank, V. Papanastassiou, J. Nicoll, D. Hadley, D. Brennan, R. Petty, A. MacLean, J. Harland, E. McKie, R. Mabbs, and M. Brown. 2000. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther. 7:859-866.
297. Raveh, T., A. G. Hovanessian, E. F. Meurs, N. Sonenberg, and A. Kimchi. 1996. Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons. J. Biol. Chem. 271:25479-25484.
298. Rhoads, R. E. 1993. Regulation of eukaryotic protein synthesis by initiation factors. J. Biol. Chem. 268:3017-3020.
299. Rivas, C., J. Gil, Z. Melkova, M. Esteban, and M. Diaz-Guerra. 1998. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 243:406-414.
300. Rivas, C., A. E. Thlick, C. Parravicini, P. S. Moore, and Y. Chang. 2001. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75:429-438.
301. Roberts, W. K., A. Hovanessian, R. E. Brown, M. J. Clemens, and I. M. Kerr. 1976. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature 264:477-480.
302. Roff, M., J. Thompson, M. S. Rodriguez, J. M. Jacque, F. Baleux, F. Arenzana-Seisdedos, and R. T. Hay. 1996. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo. J. Biol. Chem. 271:7844-7850.
303. Roh, M. S., J. Y. Kwak, S. J. Kim, H. W. Lee, H. C. Kwon, T. H. Hwang, P. J. Choi, and Y. S. Hong. 2005. Expression of double-stranded RNA-activated protein kinase in small-size peripheral adenocarcinoma of the lung. Pathol. Int. 55:688-693.
304. Roller, R. J., and B. Roizman. 1992. The herpes simplex virus 1 RNA binding protein US11 is a virion component and associates with ribosomal 60S subunits. J. Virol. 66:3624-3632.
305. Romano, P. R., F. Zhang, S. L. Tan, M. T. Garcia-Barrio, M. G. Katze, T. E. Dever, and A. G. Hinnebusch. 1998. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell. Biol. 18:7304-7316.
306. Roy, S., M. G. Katze, N. T. Parkin, I. Edery, A. G. Hovanessian, and N. Sonenberg. 1990. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216-1219.
307. Ruvolo, P. P., F. Gao, W. L. Blalock, X. Deng, and W. S. May. 2001. Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX. J. Biol. Chem. 276:11754-11758.
308. Salzberg, S., S. Vilchik, S. Cohen, A. Heller, and Y. Kronfeld-Kinar. 2000. Expression of a PKR dominant-negative mutant in myogenic cells interferes with the myogenic process. Exp. Cell Res. 254:45-54.
309. Samuel, C. E. 1991. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11.
310. Samuel, C. E., K. L. Kuhen, C. X. George, L. G. Ortega, R. Rende-Fournier, and H. Tanaka. 1997. The PKR protein kinase-an interferon-inducible regulator of cell growth and differentiation. Int. J. Hematol. 65:227-237.
311. Sarkar, D., Z. Z. Su, I. V. Lebedeva, M. Sauane, R. V. Gopalkrishnan, K. Valerie, P. Dent, and P. B. Fisher. 2002. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. USA 99:10054-10059.
312. Sarrazin, C., M. Bruckner, E. Herrmann, B. Ruster, K. Bruch, W. K. Roth, and S. Zeuzem. 2001. Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PcPHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy. Virology 289:150-163.
313. Sarrazin, C., I. Kornetzky, B. Ruster, J. H. Lee, B. Kronenberger, K. Bruch, W. K. Roth, and S. Zeuzem. 2000. Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response. Hepatology 31:1360-1370.
314. Saunders, L. R., and G. N. Barber. 2003. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17:961-983.
315. Savkur, R. S., and M. O. Olson. 1998. Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease. Nucleic Acids Res. 26:4508-4515.
316. Schiappa, D. A., C. Mittal, J. A. Brown, and B. P. Mika. 2002. Relationship of hepatitis C genotype I NS5A sequence mutations to early phase viral kinetics and interferon effectiveness. J. Infect. Dis. 185:868-877.
317. Schlee, M., V. Hornung, and G. Hartmann. 2006. siRNA and isRNA: two edges of one sword. Mol. Ther. 14:463-470.
318. Sedger, L., and J. Ruhy. 1994. Heat shock response to vaccinia virus infection. J. Virol. 68:4685-4689.
319. Sekellick, M. J., S. A. Carra, A. Bowman, D. A. Hopkins, and P. I. Marcus. 2000. Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes. J. Interferon Cytokine Res. 20:963-970.
320. Sen, A., R. Steele, A. K. Ghosh, A. Basu, R. Ray, and R. B. Ray. 2003 Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res. 96:27-35.
321. Sen, G. C., and P. Lengyel. 1992. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267:5017-5020.
322. Sen, G. C., H. Taira, and P. Lengyel. 1978. Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. J. Biol. Chem. 253:5915-5921.
323. SenGupta, D. N., B. Berkhout, A. Gatignol, A. M. Zhou, and R. H. Silverman. 1990. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 87:7492-7496.
324. Shang, Y., C. R. Baumrucker, and M. H. Green. 1998. c-Myc is a major mediator of the synergistic growth inhibitory effects of retinoic acid and interferon in breast cancer cells. J. Biol. Chem. 273:30608-30613.
325. Sharp, T. V., F. Moonan, A. Romashko, B. Joshi, G. N. Barber, and R. Jagus. 1998. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. Virology 250:302-315.
326. Sharp, T. V., M. Schwemmle, I. Jeffrey, K. Laing, H. Mellor, C. G. Proud, K. Hilse, and M. J. Clemens. 1993. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res. 21: 4483-4490.
327. Sharp, T. V., J. E. Witzel, and R. Jagus. 1997. Homologous regions of the alpha subunit of eukaryotic translational initiation factor 2 (eIF2alpha) and the vaccinia virus K3L gene product interact with the same domain within the dsRNA-activated protein kinase (PKR). Eur. J. Biochem. 250:85-91.
328. Shimada, A., G. Shiota, H. Miyata, T. Kamahora, H. Kawasaki, K. Shiraki, S. Hino, and T. Terada. 1998. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res. 58:4434-4438.
329. Shir, A., I. Friedrich, and A. Levitzki. 2003. Tumor specific activation of PKR as a non-toxic modality of cancer treatment. Semin. Cancer Biol. 13:309-314.
330. Shir, A., and A. Levitzki. 2002. Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR. Nat. Biotechnol. 20:895-900.
331. Shors, T., K. V. Kibler, K. B. Perkins, R. Seidler-Wulff, M. P. Banaszak, and B. L. Jacobs. 1997. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. Virology 239:269-276.
332. Siffroi, J. P., A. Pawlak, M. F. Alfonsi, F. Troalen, G. Guellaen, and J. P. Dadoune. 2001. Expression of the TAR RNA binding protein in human testis. Mol. Hum. Reprod. 7:219-225.
333. Sionuv, R. V., and Y. Haupt. 1999. The cellular response to p53: the decision between life and death. Oncogene 18:6145-6157.
334. Sledz, C. A., M. Holko, M. J. de Veer, R. H. Silverman, and B. R. Williams. 2003. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5:834-839.
335. Smith, E. J., I. Marie, A. Prakash, A. Garcia-Sastre, and D. E. Levy. 2001. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by vaccinia virus E3L protein. J. Biol. Chem. 276:8951-8957.
336. Squire, J., E. F. Meurs, K. L. Chong, N. A. McMillan, A. G. Ilovanessian, and B. R. Williams. 1993. Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PRKR) to chromosome 2p21-p22. Genomics 16:768-770.
337. Srivastava, S. P., M. V. Davies, and R. J. Kaufman. 1995. Calcium depletion from the endoplasmic reticulum activates the double-stranded RNA-dependent protein kinase (PKR) to inhibit protein synthesis. J. Biol. Chem. 270:16619-16624.
338. Srivastava, S. P., K. U. Kumar, and R. J. Kaufman. 1998. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 273:2416-2423.
339. 333a. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiher. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
340. Stewart, M. J., M. A. Blum, and B. Sherry. 2003. PKR's protective role in viral myocarditis. Virology 314:92-100.
341. Stojdl, D. F., N. Abraham, S. Knowles, R. Marius, A. Brasey, B. D. Lichty, E. G. Brown, N. Sonenberg, and J. C. Bell. 2000. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74:9580-9585.
342. Strong, J. E., M. C. Coffey, D. Tang, P. Sahinin, and P. W. Lee. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17:3351-3362.
343. Su, Q., S. Wang, D. Baltzis, L. K. Qu, A. H. Wong, and A. E. Koromilas. 2006. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 103:63-68.
344. Sudhakar, A., A. Ramachandran, S. Ghosh, S. E. Hasnain, R. J. Kaufman, and K. V. Ramaiah. 2000. Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 39:12929-129378.
345. Sugimoto, M., M. L. Kuo, M. F. Roussel, and C. J. Sherr. 2003. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell 11: 415-424.
346. Syed, V., K. Mukherjee, J. Lyons-Weiler, K. M. Lau, T. Mashima, T. Tsuruo, and S. M. Ho. 2005. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24:1774-1787.
347. Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551-560.
348. Taddeo, B., T. R. Luo, W. Zhang, and B. Roizmann. 2003. Activation of NF-kappaB in cells productively infected with HSV-I depends on activated protein kinase R and plays no apparent role in blocking apoptosis. Proc. Natl. Acad. Sci. USA 100:12408-12413.
349. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
350. Takizawa, T., K. Ohashi, and Y. Nakanishi. 1996. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 70:8128-8132.
351. Talon, J., C. M. Horvath, R. Polley, C. F. Basler, T. Muster, P. Palese, and A. Garcia-Sastre. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74:7989-7996.
352. Tamura, K., B. Hua, S. Adachi, I. Guney, J. Kawauchi, M. Morioka, M. Tamamori-Adachi, Y. Tanaka, Y. Nakabeppu, M. Sunamori, J. M. Sedivy, and S. Kitajima. 2005. Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. EMBO J. 24:2590-2601.
353. Tan, S., Y. Sagara, Y. Liu, P. Maher, and D. Schuhert. 1998. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141:1423-1432.
354. Tan, S. L., and M, G. Katze. 1998. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon Cytokine Res. 18: 757-766.
355. Tan, S. L., and M. G. Katze. 2001. Flow hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 284:1-12.
356. Tanaka, H., and C. E. Samuel. 1994. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91:7995-7999.
357. Tang, N. M., M. J. Korth, M. Gale, Jr., M. Wambach, S. D. Der, S. K. Bandyopadhyay, B. K. Williams, and M. G. Katze. 1999. Inhibition of double-stranded RNA- and tumor necrosis factor alpha-mediated apoptosis by tetratricopeptide repeat protein and cochaperone P58(IPK). Mol. Cell. Biol. 19:4757-4765.
358. Taniguchi, T., and A. Takaoka. 2002. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14:111-116.
359. Taylor, D. R., S. B. Lee, P. R. Romano, D. K. Marshak, A. G. Hinnebusch, M. Esteban, and M. B. Mathews. 1996. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol. Cell. Biol. 16:6295-6302.
360. Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber, and M. M. Lai. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
361. Taylor, S. S., N. M. Haste, and G. Ghosh. 2005. PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking. Cell 122:823-825.
362. Terada, T., H. Maeta, K. Endo, and T. Ohta. 2000. Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling. Hum. Pathol. 31:817-821.
363. Terada, T., J. Ueyama, V. Ukita, and T. Ohta. 2000. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma. Liver 20:450-457.
364. Turk, B. E., E. C. Griffith, S. Wolf, K. Biemann, Y. H. Chang, and J. O. Liu. 199. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Chem. Biol. 6:823-833.
365. Ung, T. L., C. Cao, J. Lu, K. Ozato, and T. K. Dever. 2001. Heterologous dimerization domains functionally substitute for the double-stranded RNA binding domains of the kinase PKR. EMBO J. 20:3728-3737.
366. Valyi-Nagy, T., M. U. Fareed, J. S. O'Keefe, R. M. Gesser, A. R. MacLean, S. M. Brown, J. G. Spivack, and N. W. Fraser. 1994. The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. J. Gen. Virol. 75:2059-2063.
367. Reference deleted.
368. Reference deleted.
369. Ventoso, I., M. A. Sanz, S. Molina, J. J. Berlanga, L. Carrasco, and M. Esteban. 2006. Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR. Genes Dev. 20:87-100.
370. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
371. Visvanathan, K. V., and S. Goodbourn. 1989. Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO J. 8:1129-1138.
372. von Holzen, U., D. Boeangel, A. Pataer, S. A. Vorburger, Y. Liu, X. Lu, K. K. Hunt, and S. G. Swisher. 2005. Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer. Surgery 138:261-268.
373. Vorhurger, S. A., N. Iletrakul, W. Xia, M. Wilson-Heiner, N. Mirza, R. E. Pollock, B. Feig, S. G. Swisher, and K. K. Hunt. 2005. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Mol. Cancer Ther. 4:1710-1716.
374. Vorburger, S. A., A. Pataer, S. G. Swisher, and K. K. Hunt. 2004. Genetically targeted cancer therapy: tumor destruction by PKR activation. Am. J. Pharmacogenomics 4:189-198.
375. Vorhurger, S. A., A. Pataer, K. Yoshida, G. N. Barher, W. Xia, P. Chiao, L. M. Ellis, M. C. Hung, S. G. Swisher, and K. K. Hunt. 2002. Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene 21:6278-6288.
376. Wada, N., M. Matsumura, Y. Ohba, N. Kobayashi, T. Takizawa, and Y. Nakanishi. 1995. Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J. Biol. Chem. 270:18007-18012.
377. Wang, X., M. Li, H. Zheng, T. Muster, P. Palese, A. A. Beg, and A. Garcia-Sastre. 2000. Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon. J. Virol. 74:11566-11573.
378. Watanabe, M. A., L. R. de Souza, J. M. Murad, and F. L. De Lucca. 2005. Activation of the RNA-dependent protein kinase (PKR) of lymphocytes by regulatory RNAs: implications for immunomodulation in HIV infection. Curr. HIV Res. 3:329-337.
379. Watson, J. C., H. W. Chang, and B. L. Jacobs. 1991. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology 185:206-216.
380. Wesche, H., W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837-847.
381. Wilson, J. E., T. V. Pestova, C. U. Hellen, and P. Sarnow. 2000. Initiation of protein synthesis from the A site of the ribosome. Cell 102:511-520.
382. Williams, B. R. 1999. PKR: a sentinel kinase for cellular stress. Oncogene 18:6112-6120.
383. Williams, B. R. 1997. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 25:509-513.
384. Williams, B. R. 2001. Signal integration via PKR. Sci. STKE 2001:RE2.
385. Willman, C. L., C. E. Sever, M. G. Pallavicini, H. Harada, N. Tanaka, M. L. Slovak, H. Yamamoto, K. Harada, T. C. Meeker, A. F. List, et al. 1993. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971.
386. Woldehawariat, G., S. Nekhai, and R. Petryshyn. 1999. Differential phosphorylation of PKR associates with deregulation of eIF-2alpha phosphorylation and altered growth characteristics in 3T3-F442A fibroblasts. Mol. Cell. Biochem. 198:7-17.
387. Wong, A. H., N. W. Tam, Y. L. Yang, A. R. Cuddihy, S. Li, S. Kirchhoff, H. Hauser, T. Decker, and A. E. Koromilas. 1997. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16:1291-1304.
388. Wu, M. H., and B. Y. Yung. 2002. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. J. Biol. Chem. 277:48234-48240.
389. Wu, S., K. U. Kumar, and R. J. Kaufman. 1998. Identification and requirement of three ribosome binding domains in dsRNA-dependent protein kinase (PKR). Biochemistry 37:13816-13826.
390. Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
391. Yajima, M., T. Kanda, and K. Takada. 2005. Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J. Virol. 79:4298-4307.
392. Yaman, I., J. Fernandez, H. Liu, M. Caprara, A. A. Komar, A. E. Koromilas, L. Zhou, M. D. Snider, D. Scheuner, R. J. Kaufman, and M. Hatzoglou. 2003. The zipper model of translational control: a small upstream ORF is the switch that controls structural remodeling of an mRNA leader. Cell 113:519-531.
393. Yamaoka, S., G. Courtois, C. Bessia, S. T. Whiteside, R. Weil, F. Agou, H. E. Kirk, R. J. Kay, and A. Israel. 1998. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93:1231-1240.
394. Yan, C., M. S. Jamaluddin, B. Aggarwal, J. Myers, and D. D. Boyd. 2005. Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol. Cancer Ther. 4:233-241.
395. Yan, C., D. Lu, T. Hai, and D. D. Boyd. 2005. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J. 24:2425-2435.
396. Yang, Y. L., L. F. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B. R. Williams, M. Aguet, and C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14: 6095-6106.
397. Yeung, M. C., D. L. Chang, R. E. Camantigue, and A. S. Lau. 1999. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proc. Natl. Acad. Sci. USA 96:11860-11865.
398. Yeung, M. C., J. Liu, and A. S. Lau. 1996. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. USA 93:12451-12455.
399. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-1 has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
400. Yue, Z., and A. J. Shatkin. 1997. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. Virology 234: 364-371.
401. Yuwen, H., J. H. Cox, J. W. Yewdell, J. R. Bennink, and B. Moss. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195:732-744.
402. Zamanian-Daryoush, M., S. D. Der, and B. R. Williams. 1999. Cell cycle regulation of the double stranded RNA activated protein kinase, PKR. Oncogene 18:315-326.
403. Zamanian-Daryoush, M., T. H. Mogensen, J. A. DiDonato, and B. R. Williams. 2000. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Mol. Cell. Biol. 20:1278-1290.
404. Zhang, C., J. Kawauchi, M. T. Adachi, Y. Hashimoto, S. Oshiro, T. Aso, and S. Kitajima. 2001. Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem. Biophys. Res. Commun. 289:718-724.
405. Zhang, F., P. R. Romano, T. Nagamura-Inoue, B. Tian, T. E. Dever, M. B. Mathews, K. Ozato, and A. G. Hinnebusch. 2001. Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J. Biol. Chem. 276:24946-24958.
406. 399a. Zhou, A., J. M. Paranjape, B. A. Hassel, H. Nie, S. Shah, B. Galinski, and R. H. Silverman. 1998. Impact of RNase L overexpression on viral and cellular growth and death. J. Interferon Cytokine Res. 18:953-961.
407. Zhou, Y., A. Gobl, S. Wang, M. B. Jacobsen, E. T. Janson, G. K. Haines III, J. A. Radosevich, and K. Oberg. 1998. Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours. Eur. J. Cancer 34:2046-2052.
408. Zhu, S., P. R. Romano, and R. C. Wek. 1997. Ribosome targeting of PKR is mediated by two double-stranded RNA-binding domains and facilitates in vivo phosphorylation of eukaryotic initiation factor-2. J. Biol. Chem. 272:14434-14441.
409. Zurcher, T., R. M. Marion, and J. Ortin. 2000. Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity. J. Virol. 74:8781-8784.